1.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 60 to 80 Sponsor: Other Protocol IDs: PROLOG, NCT00675168
|
|
2.
|
Phase: Phase IV Type: Supportive care Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2612-3681, NCT00724581
|
|
3.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 Sponsor: Other Protocol IDs: P080204, IDRCB 2008-A01386-49, NCT00925444
|
|
4.
|
Phase: Phase IV Type: Supportive care Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 11021, NCT01381627
|
|
5.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 50 and over Sponsor: Other Protocol IDs: VMT-SPiN_01, NCT01389154
|
|
6.
|
Phase: Phase IV Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PAN-001, NCT01658280
|
|
7.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: Haema CBF SCLC UK/AS 01, NCT00168896
|
|
8.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: INCAN/CC/330/09, CA171/CB/558/09, NCT01048970
|
|
9.
|
Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 201106336, NCT01446874
|
|
10.
|
Phase: Phase III, Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: GLiang, NCT01498055
|
|
11.
|
Phase: Phase III Type: Diagnostic Status: Active Age: 19 to 90 Sponsor: Other Protocol IDs: R05-0076, NCT00207298
|
|
12.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2005P000376, NCT00300495
|
|
13.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000531141, CRUK-LUNGSTAR, EU-20649, ISRCTN56306957, EUDRACT-2005-005821-71, UCL-BRD/05/129, MREC-06-MRE10-28, CTA-20363-0215-001, CTAAC-C1312-A5335, CTAAC-C1312-A12462, NCT00433498
|
|
14.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000531709, CHNT-CONVERT, CHNT-CTAAC-CONVERT-C17052/A815, EU-20669, CHNT-CTAAC-CONVERT-C17052/A8152, NCT00433563
|
|
15.
|
Phase: Phase III Type: Health services research, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000561532, WCTU-FRAGMATIC, Velindre-FRAGMATIC, WCTU-02, EU-20753, PFIZER-WCTU-02, EUDRACT-2005-002438-37, ISRCTN80812769, NCT00519805
|
|
16.
|
Phase: Phase III Type: Treatment Status: Active Age: 70 and under Sponsor: Other Protocol IDs: STAD-1, 2006-003995-36, NCT00526396
|
|
17.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CALGB-30610, CALGB 30610, RTOG 0538, NCT00632853
|
|
18.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: BM004, NCT00656305
|
|
19.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ELCWP 01994, NCT00658580
|
|
20.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EudraCT number 2007-006033-14, NCT00717938
|
|
21.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: DOLG7, NCT00812266
|
|
22.
|
Phase: Phase III Type: Treatment Status: Active Age: 19 to 80 Sponsor: Other Protocol IDs: CSCLC-0810, NCT00826644
|
|
23.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 25387, 1 R01 HL95109-01, NCT00876915
|
|
24.
|
Phase: Phase III Type: Diagnostic Status: Active Age: 18 and over Sponsor: Other Protocol IDs: AMI-2008-01, NCT00882609
|
|
25.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CHU-0064, NCT01053624
|